PATENT CLAIM ANALYSIS

Application Number: 16296012
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "356000"]

Abstract:
Disclosed herein are methods of treating disease with a combination of a RXR agonist and a thyroid hormone.

Claim (Index 21):
The method of  claim 15 , wherein the neurotrophic factor is BDNF.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16118001', '15339762', '15812821', '15339752', '14507730']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8674948978679309
- 35 USC 102 Novelty (BERT): 0.6371378475623571
- Combined Prediction Score: 0.8444591928373735
- Mean Citation Score: 701.6502839999997
- Max Citation Score: 781.9381
- Similarity Product: 526.712166646862

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test